平滑肌瘤
姜黄素
细胞外基质
子宫肌瘤
医学
细胞凋亡
癌症研究
内科学
药理学
内分泌学
病理
化学
生物化学
作者
Minnie Malik,Joy L. Britten,Anthony DeAngelis,Collin A. Sitler,Sean Moran,Jaime A. Roura-Monilor,Paul Driggers,William H. Catherino
标识
DOI:10.1016/j.xfss.2022.10.004
摘要
Abstract
Background
Current medical therapies for uterine leiomyomas have substantial side-effects and therefore are not commonly used for the treatment of pre-symptomatic disease. Highly tolerated therapeutic options are required to provide options for women who will likely progress to symptomatic disease. Curcumin efficacy in supportive care of various clinical conditions have been well documented. Pre-clinical, in-vitro studies have demonstrated decreased proliferation and extracellular matrix protein production In uterine leiomyoma. Purpose
The main objective of our study was to determine if a curcumin supplemented diet would prevent and/or treat uterine leiomyoma growth in our mouse xenograft model. Design
Animal study Intervention
Curcumin supplemented diet Results
We found that curcumin was well tolerated as a dietary supplement, that free curcumin and its metabolites were detected in the serum, and that exposure resulted in approximately 60% less leiomyoma xenograft growth as well as dissolution of the peripheral extracellular matrix architecture of the xenografts. Matrix proteins, including collagens, were decreased, while there was an increase in apoptotic cells in the xenografts. Additionally, when xenografts were placed in a uterine intramural location, we found a significantly increased apoptotic response to curcumin in the diet. Conclusion
Mice on a diet supplemented with curcumin could achieve serum levels sufficient to regulate human leiomyoma xenograft growth and play both preventive and curative role in treatment of uterine leiomyoma as an oral nutritional supplement.
科研通智能强力驱动
Strongly Powered by AbleSci AI